This topic contains a solution. Click here to go to the answer

Author Question: A 70-year-old patient who has a high fracture risk has been taking alendronate (Fosamax) and calcium ... (Read 82 times)

Caiter2013

  • Hero Member
  • *****
  • Posts: 607
A 70-year-old patient who has a high fracture risk has been taking alendronate (Fosamax) and calcium for 6 months. The primary care NP orders a urine NTx level, which is 42 . The NP should discontinue the alendronate and prescribe:
 
  a. raloxifene (Evista).
  b. teriparatide (Forteo).
  c. calcitonin (Miacalcin nasal spray).
  d. ibandronate sodium (Boniva).

Question 2

A patient takes hydrochlorothiazide to treat hypertension and asks the primary care NP why it is necessary to reduce sodium intake while taking this medication. The NP should explain that decreasing sodium is necessary to:
 
  a. prevent renal insufficiency.
  b. minimize the risk of hypokalemia.
  c. prevent postdiuretic sodium retention.
  d. increase the likelihood that the drug may be discontinued.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

heyhey123

  • Sr. Member
  • ****
  • Posts: 353
Answer to Question 1

B
Teriparatide is used in patients with a high fracture risk or in whom bisphosphonate therapy has failed. Raloxifene and ibandronate are second-line treatments for patients with usual fracture risks. Calcitonin is a last-line treatment.

Answer to Question 2

C
If dietary salt intake is high, the amount of sodium lost in response to the diuretic may be partially or completely offset by postdiuretic sodium retention. Sodium restriction does not prevent renal insufficiency or minimize the incidence of hypokalemia. Sodium restriction is necessary to maintain the drug's effectiveness but does not increase the chance of discontinuing the medication.




Caiter2013

  • Member
  • Posts: 607
Reply 2 on: Jul 24, 2018
Gracias!


cpetit11

  • Member
  • Posts: 321
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

There are more sensory neurons in the tongue than in any other part of the body.

Did you know?

Human neurons are so small that they require a microscope in order to be seen. However, some neurons can be up to 3 feet long, such as those that extend from the spinal cord to the toes.

Did you know?

Eat fiber! A diet high in fiber can help lower cholesterol levels by as much as 10%.

Did you know?

This year, an estimated 1.4 million Americans will have a new or recurrent heart attack.

For a complete list of videos, visit our video library